Left Ventricular Mass is Associated with Biopsy-Assessed Renal Fibrosis in Chronic Kidney Disease

Carl G Glessgen1, Aurélie Huber2, Lindsey A Crowe1

  • 1Diagnostic Department, Division of Radiology, University Hospitals of Geneva, Geneva, Switzerland.

Insights

In chronic kidney disease (CKD) patients, increased left ventricular mass is linked to renal interstitial fibrosis, independent of kidney function. This suggests structural kidney damage offers insights beyond estimated glomerular filtration rate (eGFR).

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Left ventricular remodeling is a predictor of cardiovascular mortality in chronic kidney disease (CKD).
  • Previous research linked renal function markers to cardiac structural changes, but the relationship between cardiac MRI parameters and renal interstitial fibrosis is not well understood.
  • This study investigated the association between cardiac remodeling and biopsy-proven renal interstitial fibrosis in CKD patients.

Purpose of the Study:

  • To investigate the association between cardiac remodeling, assessed by cardiac MRI, and biopsy-assessed renal interstitial fibrosis in patients with CKD.
  • To determine if cardiac structural changes correlate with the degree of renal interstitial fibrosis.
  • To explore the independent association of cardiac remodeling with renal fibrosis beyond kidney function markers like eGFR.

Main Methods:

  • Prospective single-center cohort study of CKD patients with native kidneys.
  • Simultaneous cardiac MRI and renal biopsy performed within the same week.
  • Renal interstitial fibrosis quantified as a percentage of affected cortex area.
  • Cardiac parameters analyzed included left ventricular mass index (LVMi), left ventricular end-diastolic volume index (LVEDVi), global longitudinal strain (GLS), global circumferential strain (GCS), and myocardial T1.
  • Associations assessed using Spearman correlations and multivariable linear regression adjusted for age and eGFR.

Main Results:

  • Forty-seven CKD patients were included (median age 49 years, 55% male).
  • Left ventricular mass index (LVMi) showed a significant correlation with renal fibrosis (ρ = 0.49; p < 0.001).
  • Renal fibrosis remained associated with LVMi after adjustment for age and eGFR (β = 0.33; p < 0.001).
  • The association between LVMi and renal fibrosis persisted even after excluding patients with high LVMi or high fibrosis grades.

Conclusions:

  • Left ventricular mass is associated with biopsy-assessed renal interstitial fibrosis in CKD patients, independent of eGFR.
  • Structural renal injury provides prognostic information beyond kidney function alone.
  • The link between renal fibrosis and left ventricular remodeling is not fully explained by volume-related hemodynamic factors, as the association was only partially attenuated after adjusting for LV volume.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...